---
figid: PMC9639665__jpet.122.001222f7
pmcid: PMC9639665
image_filename: jpet.122.001222f7.jpg
figure_link: /pmc/articles/PMC9639665/figure/F7/
number: Fig. 7
figure_title: ''
caption: Proposed bioactivation pathway of INF by CYP2J2.
article_title: 'Identification of Infigratinib as a Potent Reversible Inhibitor and
  Mechanism-Based Inactivator of CYP2J2: Nascent Evidence for a Potential In Vivo
  Metabolic Drug-Drug Interaction with Rivaroxaban.'
citation: Lloyd Wei Tat Tang, et al. J Pharmacol Exp Ther. 2022 Aug;382(2):123-134.
year: '2022'

doi: 10.1124/jpet.122.001222
journal_title: The Journal of Pharmacology and Experimental Therapeutics
journal_nlm_ta: J Pharmacol Exp Ther
publisher_name: The American Society for Pharmacology and Experimental Therapeutics

keywords:
---
